Deciphera Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCPH and other ETFs, options, and stocks.

About DCPH

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. 

CEO
Steven L. Hoerter
CEOSteven L. Hoerter
Employees
355
Employees355
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2003
Founded2003
Employees
355
Employees355

DCPH Key Statistics

Market cap
2.20B
Market cap2.20B
Price-Earnings ratio
-11.52
Price-Earnings ratio-11.52
Dividend yield
—
Dividend yield—
Average volume
1.93M
Average volume1.93M
High today
$25.47
High today$25.47
Low today
$25.44
Low today$25.44
Open price
$25.46
Open price$25.46
Volume
1.15M
Volume1.15M
52 Week high
$25.55
52 Week high$25.55
52 Week low
$9.90
52 Week low$9.90

Analyst ratings

89%

of 9 ratings
Buy
11.1%
Hold
88.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.